2011

The Chief Academic Officer of the Center for Integration of Medicine and Innovative Technology urges busy doctors not to ignore the ideas they have for improving medicine.

This week, eMed will be providing coverage of Partnering for Cures, a conference bringing together leaders in biotech research to discuss the healthcare business landscape.

The U.S. Food and Drug Administration's laborious and lengthy approval process is hitting healthcare business owners in the pocketbook. But the FDA could be hitting consumers worse.

Medical device startups will be way ahead of their competitors if they know what to expect from the FDA approval process. Read more for tips on how to be prepared.

Finally, the U.S. Food and Drug Administration is getting around to regulating mobile health applications. It's early in the game, but what do the new rules look like?

Federal regulations and overseas competition are just two of the barriers holding back medical device innovation, says one medical device industry executive. Read more about the other roadblocks to innovation.

Despite having a great product, your company can suffer from mistakes made during the product launch. Here are five tips on avoiding the mistakes others have made.

Academia is getting ever more aggressive about helping entrepreneurs get a running start. An emerging crown jewel could well be Stanford University's brand new StartX.

Many would agree that surgeons are qualified to create innovative medical devices that may be superior to what is currently available. But the controversy arises when surgeons begin to profit by purchasing their own products for use in their patients.

At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.